Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BX vs GSK✓SelectedUSD · GSKBX vs GSK performance historyLatest closeAs of-4.47%11/20
Stock and ETF performance explorer

BX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-8.5%
GSK return
+40.7%
Excess return
-49.1%
Maximum drawdown
-49.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.5%-0.1%-4.3%-4.4%
7D-7.8%-5.3%-2.5%-6.6%
30D+2.1%-3.7%+5.7%+3.0%
3M-20.9%-7.3%-13.6%-19.5%
6M-3.3%-4.2%+1.0%-2.3%
YTD-25.2%+0.9%-26.0%-25.5%
1Y-16.7%+7.3%-23.9%-18.3%
3Y+14.6%+52.7%-38.2%-1.4%
All-8.5%+40.7%-49.1%-27.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling